Pictet Asset Management (UK)’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Pictet Asset Management (UK)’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-188,200	Closed	-$2.69M	–	903
2014 Q4	$2.69M	Buy	188,200 +2,400	+1%	+$25.3K	0.01%	709
2014 Q3	$1.21M	Sell	185,800 -101,100	-35%	-$671K	0.01%	781
2014 Q2	$1.98M	Buy	286,900 +88,200	+44%	+$624K	0.01%	738
2014 Q1	$1.42M	Buy	198,700 +5,200	+3%	+$44.5K	0.01%	765
2013 Q4	$1.82M	Buy	+193,500	New	+$1.38M	0.01%	749

Other funds holding SCMP

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Pictet Asset Management (UK)'s SCMP Position: Q1 2015 in Review

Pictet Asset Management (UK) sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2015, closing a stake of 188,200 shares — an estimated $2.69M sold.

Pictet Asset Management (UK) first reported a position in SCMP in Q4 2013 and held it in 5 quarters. The position peaked at $2.69M in Q4 2014. 125 funds tracked by Wall St. Rank hold SCMP as of Q1 2015.

Pictet Asset Management (UK) reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2015 after selling out during the quarter.
Pictet Asset Management (UK) sold 188,200 Sucampo Pharmaceuticals, Inc. shares in Q1 2015, an estimated $2.69M.
Pictet Asset Management (UK) first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2013 and held it in 5 quarters.
Pictet Asset Management (UK)'s Sucampo Pharmaceuticals, Inc. position peaked at $2.69M in Q4 2014.
125 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2015.

Based on Pictet Asset Management (UK)'s 13F filing for Q1 2015, filed 13 May 2015.